Showing results (91-100 of 154) with videos related to
Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|January 22, 2024
Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in AfricaSuthunya Chupradit, Dalton C Wamalwa, Elizabeth Maleche-Obimbo, et al.The Journal of Antimicrobial Chemotherapy|July 5, 2017
Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan childrenCissy Kityo, Ragna S Boerma, Kim C E Sigaloff, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 TrialLisanne A H Bevers, Hylke Waalewijn, Alexander J Szubert, et al.Plos One|February 5, 2026
Impact of COVID-19 on New - onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, UgandaRosemary Ahabwenki, Thereza Piloya, Flavia Namiiro, et al.Journal of the Pediatric Infectious Diseases Society|October 5, 2023
Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight BandsSuthunya Chupradit, Dalton C Wamalwa, Elizabeth Maleche-Obimbo, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 26, 2026
Vascular and Inflammatory Biomarkers Linked to Neurocognition in Ugandan Youth with Perinatal HIV on DolutegravirCaroline M Carlson, Shan Sun, Christine Karungi, et al.Discover Public Health|July 16, 2026
Association of childhood adversity and depression with cardiovascular health in youth with perinatal HIV 1 in UgandaSara K Aljohani, Shan Sun, Christine Karungi, et al.The Pediatric Infectious Disease Journal|February 15, 2013
Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and ZimbabweVictor Musiime, Adrian Cook, Sabrina Bakeera-Kitaka, et al.The Pediatric Infectious Disease Journal|July 29, 2014
Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapyMutsawashe Bwakura-Dangarembizi, Victor Musiime, Alexander J Szubert, et al.Nature Communications|June 29, 2024
Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan AfricaVictor Riitho, Roisin Connon, Agnes Gwela, et al.Pageof 16